Complete Filing Data
Janux Therapeutics, Inc. reported Stockholders Equity of $956.82 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Janux Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$113.6M | -$69.0M | -$58.3M | -$63.1M | -$32.7M | -$6.8M |
| Revenue From Contract With Customer Including Assessed Tax | $10.0M | $10.6M | $8.1M | $8.6M | $3.6M | $0.00 |
| Research And Development Expense | $125.9M | $68.4M | $54.9M | $53.4M | $26.2M | $3.0M |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $2.2M | $1.5M | $2.2M | -$1.3M | -$270.0K | $0.00 |
| Operating Income Loss | -$157.7M | -$98.8M | -$73.0M | -$67.1M | -$32.9M | -$4.8M |
| Nonoperating Income Expense | $44.0M | $29.9M | $14.7M | $4.0M | $257.0K | -$1.9M |
| General And Administrative Expense | $41.8M | $41.0M | $26.1M | $22.3M | $10.3M | $1.8M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$111.5M | -$67.5M | -$56.1M | -$64.3M | -$32.9M | -$6.8M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $2.2M | $1.5M | $2.2M | -$1.3M | -$270.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$24.3M | -$33.9M | -$23.5M | -$28.1M | -$6.0M | -$14.8M | -$11.6M | -$17.5M | -$17.5M | -$16.7M | -$16.9M | -$13.4M | -$10.8M | -$6.2M | -$2.3M | -$1.3M | -$2.5M |
| Revenue From Contract With Customer Including Assessed Tax | $10.0M | $0.00 | $0.00 | $439.0K | $8.9M | $1.3M | $2.5M | $1.1M | $2.0M | $1.8M | $2.4M | $1.6M | $1.2M | $482.0K | $380.0K | $0.00 | $0.00 |
| Research And Development Expense | $34.6M | $34.7M | $25.1M | $18.6M | $14.9M | $14.1M | $11.9M | $14.9M | $15.9M | $13.7M | $14.1M | $10.2M | $8.4M | $4.7M | $1.9M | $834.0K | $673.0K |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $815.0K | -$9.0K | $1.6M | $9.4M | -$1.1M | -$1.2M | -$115.0K | -$321.0K | $796.0K | -$370.0K | -$340.0K | -$1.6M | $7.0K | $17.0K | $0.00 | $0.00 | $0.00 |
| Operating Income Loss | -$35.3M | -$45.1M | -$34.9M | -$35.8M | -$13.8M | -$20.2M | -$15.8M | -$20.7M | -$20.3M | -$18.0M | -$17.3M | -$13.5M | -$10.9M | -$6.3M | -$2.3M | -$1.3M | -$1.1M |
| Nonoperating Income Expense | $10.9M | $11.3M | $11.4M | $7.8M | $7.9M | $5.4M | $4.2M | $3.2M | $2.8M | $1.3M | $373.0K | $132.0K | $137.0K | $46.0K | $0.00 | $0.00 | -$1.4M |
| General And Administrative Expense | $10.6M | $10.5M | $9.8M | $17.7M | $7.8M | $7.3M | $6.4M | $6.9M | $6.5M | $6.1M | $5.5M | $4.9M | $3.7M | $2.0M | $739.0K | $422.0K | $433.0K |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$23.5M | -$33.9M | -$21.9M | -$18.6M | -$7.1M | -$15.9M | -$11.7M | -$17.8M | -$16.7M | -$17.1M | -$17.2M | -$15.0M | -$10.8M | -$6.2M | -$2.3M | -$1.3M | -$2.5M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $815.0K | -$9.0K | $1.6M | $9.4M | -$1.1M | -$1.2M | -$115.0K | -$321.0K | $796.0K | -$370.0K | -$340.0K | -$1.3M | $7.0K | $17.0K | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $956.8M | $1.02B | $344.3M | $320.7M | $366.3M | -$14.6M | -$7.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $53.2M | $431.4M | $20.0M | $52.2M | $36.4M | $7.8M | $658.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$378.3M | $411.4M | -$32.2M | $15.8M | $28.6M | $7.2M | |
| Accretion Amortization Of Discounts And Premiums Investments | $17.6M | $10.6M | $7.7M | $2.2M | $172.0K | $0.00 | |
| Short Term Investments | $914.2M | $594.6M | $324.8M | $275.6M | $339.4M | $0.00 | |
| Retained Earnings Accumulated Deficit | -$351.4M | -$237.8M | -$168.8M | -$110.5M | -$47.4M | -$14.7M | |
| Property Plant And Equipment Net | $3.9M | $4.9M | $7.0M | $7.1M | $1.4M | $155.0K | |
| Prepaid Expense And Other Assets Current | $9.3M | $8.5M | $5.2M | $5.4M | $2.1M | $249.0K | |
| Liabilities Current | $25.0M | $17.5M | $13.0M | $16.5M | $12.8M | $3.2M | |
| Liabilities And Stockholders Equity | $1.00B | $1.06B | $380.4M | $364.0M | $379.8M | $16.2M | |
| Liabilities | $44.7M | $38.7M | $36.1M | $43.3M | $13.5M | $9.2M | |
| Common Stock Value | $60.0K | $59.0K | $46.0K | $42.0K | $41.0K | $1.0K | |
| Cash And Cash Equivalents At Carrying Value | $52.3M | $430.6M | $19.2M | $51.4M | $35.6M | $7.8M | |
| Assets Current | $975.9M | $1.03B | $349.2M | $332.4M | $377.0M | $16.1M | |
| Assets | $1.00B | $1.06B | $380.4M | $364.0M | $379.8M | $16.2M | |
| Additional Paid In Capital Common Stock | $1.30B | $1.26B | $512.4M | $432.7M | $414.0M | $100.0K | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $4.3M | $2.2M | $665.0K | -$1.5M | -$270.0K | $0.00 | |
| Accrued Liabilities Current | $17.6M | $11.7M | $7.4M | $8.2M | $3.8M | $751.0K | |
| Accounts Payable Current | $5.0M | $4.0M | $2.4M | $2.2M | $2.5M | $428.0K | |
| Other Assets Noncurrent | $2.6M | $2.9M | $2.5M | $1.4M | $392.0K | $0.00 | |
| Operating Lease Right Of Use Asset | $18.4M | $19.3M | $20.8M | $22.3M | $185.0K | $0.00 | |
| Operating Lease Liability Current | $2.4M | $1.7M | $1.5M | $763.0K | $194.0K | $0.00 | |
| Vesting Of Restricted Common Stock | $0.00 | $20.0K | $149.0K | $1.0M | $475.0K | $2.0K | |
| Restricted Cash Noncurrent | $816.0K | $816.0K | $816.0K | $816.0K | $816.0K | $0.00 | |
| Operating Lease Liability Noncurrent | $19.7M | $21.3M | $23.0M | $24.5M | $0.00 | ||
| Contract With Customer Liability Current | $0.00 | $1.7M | $5.4M | $5.2M | $2.0M | ||
| Contract With Customer Liability Noncurrent | $0.00 | $2.2M | $700.0K | $6.1M | |||
| Capital Lease Obligations Incurred | $943.0K | $0.00 | $0.00 | $23.4M | $256.0K | $0.00 | |
| Unvested Stock Liabilities | $1.2M | $52.0K | |||||
| Stock Issued During Period Value Issuance Of Common Stock And Pre Funded Common Stock Warrants Net Of Issuance Costs | $697.9M | $56.5M | |||||
| Accrued Expenses Includes Related Party Amounts | -$25.0K | -$512.0K | $442.0K | ||||
| Accounts Receivable Net Current | $8.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $976.6M | $990.5M | $1.01B | $656.1M | $657.7M | $655.8M | $348.9M | $299.5M | $311.3M | $331.5M | $343.8M | $356.1M | $376.8M | $384.8M | -$16.8M | -$13.0M | -$11.8M | -$9.4M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $49.2M | $53.3M | $74.6M | $27.6M | $15.5M | $213.6M | $18.0M | $34.5M | $31.2M | $65.6M | $59.2M | $55.9M | $39.4M | $251.6M | $70.8M | $4.9M | $6.0M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$356.9M | $193.6M | -$21.1M | $19.5M | $63.0M | |||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $4.2M | $1.8M | $1.7M | $24.0K | $0.00 | |||||||||||||||||
| Short Term Investments | $940.6M | $943.6M | $940.4M | $631.3M | $631.6M | $439.0M | $332.6M | $269.6M | $286.5M | $274.0M | $295.9M | $306.1M | $348.1M | $142.6M | ||||||||
| Retained Earnings Accumulated Deficit | -$319.4M | -$295.1M | -$261.3M | -$217.5M | -$189.5M | -$183.5M | -$157.0M | -$145.4M | -$127.9M | -$94.4M | -$77.7M | -$60.8M | -$34.0M | -$23.2M | ||||||||
| Property Plant And Equipment Net | $4.3M | $4.7M | $4.9M | $5.4M | $5.9M | $6.5M | $7.3M | $7.4M | $7.2M | $6.5M | $3.5M | $2.7M | $1.1M | $215.0K | ||||||||
| Prepaid Expense And Other Assets Current | $9.1M | $9.5M | $9.2M | $8.3M | $8.1M | $6.4M | $5.5M | $6.0M | $3.8M | $5.1M | $3.8M | $3.5M | $2.1M | $2.0M | ||||||||
| Liabilities Current | $27.8M | $21.4M | $17.5M | $17.2M | $11.5M | $10.6M | $14.5M | $17.9M | $16.1M | $16.3M | $13.0M | $12.5M | $12.5M | $9.2M | ||||||||
| Liabilities And Stockholders Equity | $1.02B | $1.03B | $1.05B | $695.0M | $691.4M | $689.0M | $386.9M | $341.5M | $353.0M | $375.8M | $385.4M | $368.6M | $391.1M | $396.8M | ||||||||
| Liabilities | $48.2M | $41.7M | $38.3M | $38.9M | $33.7M | $33.2M | $37.9M | $42.0M | $41.7M | $44.2M | $41.6M | $12.5M | $14.3M | $12.0M | ||||||||
| Common Stock Value | $60.0K | $59.0K | $59.0K | $52.0K | $52.0K | $51.0K | $46.0K | $42.0K | $42.0K | $42.0K | $42.0K | $41.0K | $41.0K | $41.0K | ||||||||
| Cash And Cash Equivalents At Carrying Value | $48.4M | $52.4M | $73.7M | $26.8M | $14.7M | $212.8M | $17.2M | $33.7M | $30.4M | $64.8M | $58.4M | $55.1M | $39.4M | $251.6M | ||||||||
| Assets Current | $998.1M | $1.01B | $1.02B | $666.3M | $661.9M | $658.7M | $355.2M | $309.3M | $321.4M | $344.3M | $358.1M | $364.7M | $389.6M | $396.6M | ||||||||
| Assets | $1.02B | $1.03B | $1.05B | $695.0M | $691.4M | $689.0M | $386.9M | $341.5M | $353.0M | $375.8M | $385.4M | $368.6M | $391.1M | $396.8M | ||||||||
| Additional Paid In Capital Common Stock | $1.29B | $1.28B | $1.27B | $865.8M | $848.7M | $839.8M | $507.1M | $445.9M | $439.9M | $428.2M | $423.4M | $418.4M | $410.7M | $408.0M | ||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $4.6M | $3.7M | $3.8M | $7.8M | -$1.6M | -$524.0K | -$1.2M | -$1.1M | -$739.0K | -$2.3M | -$1.9M | -$1.6M | $24.0K | $17.0K | ||||||||
| Accrued Liabilities Current | $22.2M | $16.0M | $13.3M | $13.0M | $8.6M | $5.8M | $6.8M | $9.2M | $7.7M | $7.2M | $4.0M | $5.1M | $2.0M | $2.3M | ||||||||
| Accounts Payable Current | $3.4M | $3.5M | $2.4M | $2.5M | $1.3M | $2.3M | $2.5M | $1.9M | $2.1M | $2.9M | $3.0M | $1.9M | $3.6M | $354.0K | ||||||||
| Other Assets Noncurrent | $2.6M | $2.7M | $2.8M | $2.8M | $2.6M | $2.5M | $2.3M | $2.4M | $1.6M | $1.4M | $207.0K | $337.0K | $140.0K | |||||||||
| Operating Lease Right Of Use Asset | $18.9M | $18.5M | $18.9M | $19.7M | $20.1M | $20.5M | $21.2M | $21.6M | $21.9M | $22.7M | $22.8M | $130.0K | $238.0K | |||||||||
| Operating Lease Liability Current | $2.3M | $1.9M | $1.8M | $1.7M | $1.6M | $1.6M | $1.5M | $1.4M | $1.4M | $0.00 | $88.0K | $153.0K | $212.0K | |||||||||
| Vesting Of Restricted Common Stock | $5.0K | $134.0K | $503.0K | $8.0K | ||||||||||||||||||
| Restricted Cash Noncurrent | $816.0K | $816.0K | $816.0K | $816.0K | $816.0K | $816.0K | $816.0K | $816.0K | $816.0K | $816.0K | $816.0K | $816.0K | ||||||||||
| Operating Lease Liability Noncurrent | $20.4M | $20.3M | $20.8M | $21.7M | $22.2M | $22.6M | $23.4M | $23.8M | $24.2M | $24.1M | $23.3M | $23.0K | $0.00 | |||||||||
| Contract With Customer Liability Current | $0.00 | $94.0K | $972.0K | $3.6M | $5.3M | $4.9M | $5.9M | $5.4M | $4.6M | $5.3M | $5.1M | |||||||||||
| Contract With Customer Liability Noncurrent | $0.00 | $307.0K | $1.4M | $3.8M | $5.3M | $0.00 | $1.8M | $2.8M | ||||||||||||||
| Capital Lease Obligations Incurred | ||||||||||||||||||||||
| Unvested Stock Liabilities | $25.0K | $30.0K | $35.0K | $169.0K | $323.0K | $492.0K | $700.0K | $1.4M | ||||||||||||||
| Stock Issued During Period Value Issuance Of Common Stock And Pre Funded Common Stock Warrants Net Of Issuance Costs | $320.1M | $56.5M | ||||||||||||||||||||
| Accrued Expenses Includes Related Party Amounts | -$32.0K | -$544.0K | ||||||||||||||||||||
| Accounts Receivable Net Current | $7.5M | $519.0K | $0.00 | $750.0K | $0.00 | $500.0K | $0.00 | $0.00 | $375.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $40.2M | $33.0M | $20.0M | $17.2M | $6.9M | $72.0K |
| Payments To Acquire Property Plant And Equipment | $1.0M | $359.0K | $1.9M | $6.4M | $1.5M | $0.00 |
| Payments To Acquire Available For Sale Securities Debt | $705.2M | $470.6M | $317.3M | $294.4M | $473.6M | $0.00 |
| Net Cash Provided By Used In Operating Activities | -$82.2M | -$43.8M | -$50.6M | -$42.9M | -$17.0M | -$4.4M |
| Net Cash Provided By Used In Investing Activities | -$301.0M | -$258.0M | -$41.2M | $58.3M | -$341.0M | $0.00 |
| Net Cash Provided By Used In Financing Activities | $4.9M | $713.2M | $59.5M | $500.0K | $386.5M | $11.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $827.0K | $3.3M | -$210.0K | $3.4M | $1.8M | $249.0K |
| Increase Decrease In Deferred Revenue | $0.00 | -$1.7M | -$5.9M | $1.8M | -$2.1M | $8.0M |
| Increase Decrease In Accrued Liabilities | $6.3M | $4.4M | -$678.0K | $4.2M | $3.0M | $624.0K |
| Increase Decrease In Accounts Payable | $977.0K | $1.6M | $277.0K | -$294.0K | $2.1M | $14.0K |
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $405.3M | $212.9M | $278.0M | $359.1M | $134.1M | $0.00 |
| Increase Decrease In Other Noncurrent Assets | -$276.0K | $375.0K | $1.1M | $1.3M | $392.0K | $0.00 |
| Increase Decrease In Operating Lease Right Of Use Assets And Liabilities Net | $2.0K | -$35.0K | -$678.0K | -$3.3M | -$9.0K | $0.00 |
| Increase Decrease In Accounts Receivable | $0.00 | -$8.0M | $8.0M | |||
| Proceeds From The Issuance Of Common Stock And Pre Funded Common Stock Warrants Net Of Issuance Costs | -$347.0K | $698.3M | $56.5M | $0.00 | ||
| Proceeds From Exercise Of Common Stock Options And Employee Stock Purchase Plan | $5.3M | $15.0M | $3.0M | $500.0K | ||
| Proceeds From Exercise Of Vested And Unvested Common Stock Options And Employee Stock Purchase Plan | $500.0K | $1.8M | $70.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $9.0M | $11.0M | $10.7M | $15.4M | $5.8M | $5.6M | $4.5M | $5.5M | $5.5M | $4.6M | $4.4M | $4.0M | $2.6M | $1.3M | $123.0K | $28.0K | $2.0K |
| Payments To Acquire Property Plant And Equipment | $371.0K | $197.0K | $285.0K | $971.0K | $153.0K | ||||||||||||
| Payments To Acquire Available For Sale Securities Debt | $371.3M | $178.5M | $71.7M | $45.1M | $0.00 | ||||||||||||
| Net Cash Provided By Used In Operating Activities | -$17.0M | -$14.8M | -$13.9M | -$11.5M | $5.6M | ||||||||||||
| Net Cash Provided By Used In Investing Activities | -$340.4M | -$113.7M | -$8.7M | $31.1M | -$153.0K | ||||||||||||
| Net Cash Provided By Used In Financing Activities | $554.0K | $322.2M | $1.6M | $1.0K | $57.5M | ||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $700.0K | $1.2M | -$1.6M | $1.4M | $13.0K | ||||||||||||
| Increase Decrease In Deferred Revenue | $0.00 | -$733.0K | -$1.3M | -$1.2M | -$4.0K | ||||||||||||
| Increase Decrease In Accrued Liabilities | $1.7M | -$1.6M | -$560.0K | $1.2M | -$240.0K | ||||||||||||
| Increase Decrease In Accounts Payable | -$1.6M | -$456.0K | -$107.0K | -$740.0K | $347.0K | ||||||||||||
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $31.3M | $65.0M | $63.3M | $77.1M | $0.00 | ||||||||||||
| Increase Decrease In Other Noncurrent Assets | -$92.0K | $15.0K | $221.0K | -$55.0K | $0.00 | ||||||||||||
| Increase Decrease In Operating Lease Right Of Use Assets And Liabilities Net | $5.0K | -$20.0K | -$587.0K | -$14.0K | $0.00 | ||||||||||||
| Increase Decrease In Accounts Receivable | $0.00 | $519.0K | $750.0K | $0.00 | -$7.6M | ||||||||||||
| Proceeds From The Issuance Of Common Stock And Pre Funded Common Stock Warrants Net Of Issuance Costs | -$347.0K | $320.5M | $0.00 | ||||||||||||||
| Proceeds From Exercise Of Common Stock Options And Employee Stock Purchase Plan | |||||||||||||||||
| Proceeds From Exercise Of Vested And Unvested Common Stock Options And Employee Stock Purchase Plan | $1.6M | $1.0K | $1.6M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.83 | -$1.28 | -$1.32 | -$1.52 | -$1.39 | -$7.41 |
| Weighted Average Number Of Shares Outstanding Basic | 62.0M | 53.8M | 44.0M | 41.5M | 23.5M | |
| Weighted Average Number Of Diluted Shares Outstanding | 62.0M | 53.8M | 44.0M | 41.5M | 23.5M | |
| Earnings Per Share Basic | $-1.83 | $-1.28 | $-1.32 | $-1.52 | $-1.39 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 |
| Common Stock Shares Outstanding | 60.4M | 59.1M | 46.3M | 41.6M | 41.2M | 1.0M |
| Common Stock Shares Issued | 60.4M | 59.1M | 46.3M | 41.7M | 41.6M | 1.3M |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 9.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.39 | -$0.55 | -$0.38 | -$0.51 | -$0.11 | -$0.30 | -$0.25 | -$0.42 | -$0.42 | -$0.40 | -$0.41 | -$0.32 | -$0.26 | -$0.62 | -$2.06 | -$1.33 | -$2.76 |
| Weighted Average Number Of Shares Outstanding Basic | 62.0M | 61.9M | 61.8M | 54.6M | 54.5M | 49.0M | 45.7M | 41.8M | 41.8M | 41.5M | 41.4M | 41.3M | 41.1M | 10.0M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 62.0M | 61.9M | 61.8M | 54.6M | 54.5M | 49.0M | 45.7M | 41.8M | 41.8M | 41.5M | 41.4M | 41.3M | 41.1M | 10.0M | |||
| Earnings Per Share Basic | $-0.39 | $-0.55 | $-0.38 | $-0.51 | $-0.11 | $-0.30 | $-0.25 | $-0.42 | $-0.42 | $-0.40 | $-0.41 | $-0.32 | $-0.26 | $-0.62 | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $9.50 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||
| Common Stock Shares Outstanding | 60.1M | 59.3M | 59.2M | 52.3M | 52.2M | 51.8M | 46.2M | 41.9M | 41.8M | 41.6M | 41.5M | 41.4M | 41.2M | 41.1M | |||
| Common Stock Shares Issued | 60.1M | 59.3M | 59.2M | 52.3M | 52.2M | 51.8M | 46.2M | 41.9M | 41.8M | 41.7M | 41.7M | 41.6M | 41.6M | 41.6M | |||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating Costs And Expenses | $167.7M | $109.4M | $81.1M | $75.7M | $36.6M | $4.8M |
| Interest And Other Income | $44.0M | $29.9M | $14.7M | $4.0M | $257.0K | $0.00 |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $40.2M | $33.0M | $20.0M | $17.2M | $6.9M | $72.0K |
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $20.0K | $149.0K | $1.0M | $475.0K | $2.0K | |
| Stock Issued During Period Value Stock Options Exercised | $4.1M | $14.2M | $2.2M | $1.0K | $20.0K | $16.0K |
| Depreciation | $2.0M | $2.1M | $2.0M | $841.0K | $113.0K | $13.0K |
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $6.0K | $132.0K | $109.0K | $38.0K | $147.0K |
| Stock Issued During Period Value Employee Stock Purchase Plan | $1.2M | $792.0K | $772.0K | $499.0K | $164.0K | |
| Stock Issued During Period Shares Stock Options Exercised | 401.1K | 1.2M | 253.5K | 7.4K | 635.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Costs And Expenses | $45.3M | $45.1M | $34.9M | $36.3M | $22.7M | $21.4M | $18.3M | $21.8M | $22.3M | $19.8M | $19.6M | $15.1M | $12.1M | $6.7M | $2.7M | $1.3M | $1.1M |
| Interest And Other Income | $10.9M | $11.3M | $11.4M | $7.8M | $7.9M | $5.4M | $4.2M | $3.2M | $2.8M | $1.3M | $373.0K | $132.0K | $137.0K | $46.0K | $0.00 | $0.00 | $0.00 |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $9.0M | $11.0M | $10.7M | $15.4M | $5.8M | $5.6M | $4.5M | $5.5M | $5.5M | $4.6M | $4.4M | $4.0M | $2.6M | $1.3M | $123.0K | $28.0K | $2.0K |
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $3.0K | $5.0K | $5.0K | $5.0K | $5.0K | $134.0K | $169.0K | $209.0K | $503.0K | $148.0K | $170.0K | $8.0K | |||||
| Stock Issued During Period Value Stock Options Exercised | $493.0K | $175.0K | $901.0K | $1.6M | $2.7M | $1.7M | $79.0K | $1.6M | $1.0K | $20.0K | |||||||
| Depreciation | $519.0K | $532.0K | $453.0K | $81.0K | $9.0K | ||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $237.0K | $0.00 | $395.0K | $396.0K | $4.0K | ||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $779.0K | $473.0K | $528.0K | $307.0K | |||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 103.9K | 186.3K | 148.6K | 6.4K |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.